Ghent University Academic Bibliography

Journal Article
A1
open access

Severe liver-related outcomes in patients with hepatitis delta : results from a multi-ethnic multicenter long-term follow-up study

Arno Furquim d'Almeida, Erwin Ho, Liesbeth Govaerts, Peter Michielsen, Thomas Serste, Stefan Bourgeois, Jean Delwaide, Christophe Moreno, Hans Orlent, Hans Van Vlierberghe (UGent) , et al.

(2025) JOURNAL OF VIRAL HEPATITIS. 32(2).

Add to list

Systematic review : glycomics as diagnostic markers for hepatocellular carcinoma

Emma Butaye (UGent) , Nicky Somers (UGent) , Lorenz Grossar (UGent) , Nele Pauwels (UGent) , Sander Lefere (UGent) , Lindsey Devisscher (UGent) , Sarah Raevens (UGent) , Anja Geerts (UGent) , Leander Meuris (UGent) , Nico Callewaert (UGent) , et al.

(2024) ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 59(1). p.23-38

Add to list

Journal Article
A1
open access

A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infection

Rani Burm, Freya Van Houtte (UGent) , Lieven Verhoye (UGent) , Ahmed Atef Ahmed Abouzeid Mesalam (UGent) , S Ciesek, P Roingeard, H Wedemeyer, Geert Leroux-Roels (UGent) and Philip Meuleman (UGent)

(2023) JHEP REPORTS. 5(3).

Add to list

Journal Article
A1
open access

Virus-host protein interaction network of the hepatitis E virus ORF2-4 by mammalian two-hybrid assays

Laura Corneillie (UGent) , Irma Lemmens (UGent) , Karin Weening (UGent) , Amse De Meyer (UGent) , Freya Van Houtte (UGent) , Jan Tavernier (UGent) and Philip Meuleman (UGent)

(2023) VIRUSES-BASEL. 15(12).

Add to list

Journal Article
A1
open access

The phosphatidylserine receptor TIM1 promotes infection of enveloped hepatitis E virus

Laura Corneillie (UGent) , Irma Lemmens (UGent) , Claire Montpellier, Martin Ferrié, Karin Weening (UGent) , Freya Van Houtte (UGent) , Xavier Hanoulle, Laurence Cocquerel, Ali Amara, Jan Tavernier (UGent) , et al.

(2023) CELLULAR AND MOLECULAR LIFE SCIENCES. 80(11).

Add to list

Transmission of hepatitis E virus infection to human-liver chimeric FRG mice using patient plasma

Ibrahim Mahmoud Sayed Ibrahim (UGent) , Lander Foquet (UGent) , Lieven Verhoye (UGent) , Aliasghar Farhoudi Moghadam (UGent) , Floresence Abravanel, Geert Leroux-Roels (UGent) , Jacques Izopet and Philip Meuleman (UGent)

(2017) ANTIVIRAL RESEARCH. 141. p.150-154

Add to list

The emergence of hepatitis E virus in Europe

Ibrahim Mahmoud Sayed Ibrahim (UGent) , Koen Vercauteren, Sayed F Abdelwahab and Philip Meuleman (UGent)

(2015) FUTURE VIROLOGY. 10(6). p.763-778

Add to list

HCV animal models and liver disease

Koen Vercauteren, Ype P de Jong and Philip Meuleman (UGent)

(2014) JOURNAL OF HEPATOLOGY. 61(suppl. 1). p.S26-S33

Add to list

Novel human SR-BI antibodies prevent infection and dissemination of HCV in vitro and in humanized mice

Krzysztof Lacek, Koen Vercauteren, Katarzyna Grzyb, Mariarosaria Naddeo, Lieven Verhoye (UGent) , Marek Patryk Słowikowski, Samira Fafi-Kremer, Arvind H Patel, Thomas F Baumert, Antonella Folgori, et al.

(2012) JOURNAL OF HEPATOLOGY. 57(1). p.17-23

Add to list

Blocking HCV entry as potential antiviral therapy

Koen Vercauteren, Geert Leroux-Roels (UGent) and Philip Meuleman (UGent)

(2012) FUTURE VIROLOGY. 7(6). p.547-561

Academic Bibliography

Severe liver-related outcomes in patients with hepatitis delta : results from a multi-ethnic multicenter long-term follow-up study

Systematic review : glycomics as diagnostic markers for hepatocellular carcinoma

A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infection

Virus-host protein interaction network of the hepatitis E virus ORF2-4 by mammalian two-hybrid assays

The phosphatidylserine receptor TIM1 promotes infection of enveloped hepatitis E virus

Transmission of hepatitis E virus infection to human-liver chimeric FRG mice using patient plasma

The emergence of hepatitis E virus in Europe

HCV animal models and liver disease

Novel human SR-BI antibodies prevent infection and dissemination of HCV in vitro and in humanized mice

Blocking HCV entry as potential antiviral therapy

Contents

Support

Contact